REGEN BIOPHARMA, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 5,442.2% | 5,442.2% | -2,426.9% |
| FY2017 | 74.9% | 74.9% | -618.4% |
| FY2018 | 54.4% | 54.4% | -2,255.9% |
| FY2019 | 34.1% | 34.1% | -2,647.3% |
| FY2020 | -61.2% | -61.2% | 2,771.7% |
| FY2021 | 69.3% | 69.3% | -558.1% |
| FY2022 | -50.0% | -50.0% | 437.1% |
| FY2023 | -22.7% | -22.7% | 327.1% |
| FY2024 | 12.8% | 12.8% | -414.8% |
| FY2025 | 20.3% | 20.3% | -464.1% |